欢迎扫描下方二维码关注： -、缴费比例 职工基本医疗保险制度建立之初，用人单位费率按规 定控制在职工工资总额的6%左右，职工缴费率一般为 本人工资收入的2%,具体缴费比例主要由各统筹地区 根据实际情况确定。 ● 生育保险和职工基本医疗保险合并实施后,用人单位 职工基本医疗保险费率,按照用人单位参加两险的缴费 比例之和确定。 、缴费基数 用人单位: 职工工资总额。 职工个人:| 本人工资收入。 实际工作中,许多地方一般以上年度平均工资 计算缴费基数。新入职人员以职工本人起薪当 目的工资收入计意ঋ费基数。 征收方式 0 0 0 0 0 0 0 c C C U 用人单位及其职工: ● 用人单位通过电子税务局或前往办税服务厅申报 缴纳,职工个人缴费部分由用人单位代扣代缴。 灵活就业人员: ● 由个人向税务部门申报缴费。 征期安排 0 0 0 0 0 0 0 U C C 按照当地规定,选择按月、按季度、按半年、 按年等时限缴费。 来源 国家税务总局 欢迎扫描下方二维码关注： 温馨提醒：蓝色柳林财税室为非官方平台，是由编者以学习笔记形式建立的平台，所有笔记写作记录的文章及转发的法律法规仅供读者学习 参考之用，并非实际办税 ...

Core Viewpoint - Northeast Pharmaceutical Group has been recognized as a high-tech enterprise again, reflecting its strong capabilities in core technology research and development, as well as the transformation of scientific achievements [1][2]. Group 1: Recognition and Certification - The company has been included in the first batch of high-tech enterprises for 2025, as announced by the National High-tech Enterprise Recognition Management Work Leading Group Office [1]. - The high-tech enterprise recognition cycle is every three years, with strict requirements on the number of independent intellectual property rights, research projects, and the ability to transform scientific achievements [1]. Group 2: Research and Development Investment - The company has significantly increased its R&D investment, with a 95% year-on-year growth in R&D expenses in the first three quarters of this year [2]. - Major breakthroughs have been achieved in cutting-edge fields such as tumor immunotherapy, with multiple tumor-targeted cell therapy products under development [2]. Group 3: Strategic Importance of Recognition - The renewed recognition as a national high-tech enterprise will provide the company with tax benefits, policy support, and opportunities for high-end market collaborations, enhancing its core competitiveness and industry influence [2]. - The company currently owns five high-tech enterprises, creating a strong cluster of innovation capabilities within the group [3]. Group 4: Future Development Plans - The company plans to leverage this recognition to further increase R&D resource investment, accelerate the industrialization of scientific achievements, and optimize its product structure [3]. - The focus will be on enhancing core competitiveness and contributing to the high-quality development of the pharmaceutical industry [3].

Core Viewpoint - Canaan Technology (300412.SZ) announced that its subsidiary, Tianjin Jianan Pharmaceutical Equipment Co., Ltd. (referred to as "Jianan Pharmaceutical"), has received the "High-tech Enterprise Certificate" from the Tianjin Municipal Science and Technology Bureau, Tianjin Finance Bureau, and the State Taxation Administration of Tianjin [1] Group 1 - The certificate number is GR202512000329, issued on November 11, 2025, and is valid for three years [1] - Jianan Pharmaceutical will benefit from tax incentives as a high-tech enterprise, allowing it to pay corporate income tax at a reduced rate of 15% for three consecutive years from the date of obtaining the qualification [1]

Core Viewpoint - Canaan Technology announced that its subsidiary, Tianjin Jianan Pharmaceutical Equipment Co., Ltd., has received the "High-tech Enterprise Certificate," which provides significant tax benefits for the next three years [1] Group 1: Company Information - Canaan Technology's subsidiary, Tianjin Jianan Pharmaceutical, received the High-tech Enterprise Certificate from multiple government bodies [1] - The certificate is valid for three years, starting from November 11, 2025 [1] Group 2: Tax Benefits - As a high-tech enterprise, Tianjin Jianan Pharmaceutical will benefit from a reduced corporate income tax rate of 15% for three consecutive years [1] - This tax rate is part of the national policy aimed at supporting high-tech enterprises [1]

（文章来源：证券日报） 证券日报网讯 12月8日晚间，兰石重装发布公告称，公司及子公司兰州兰石检测技术有限公司重新认定 为国家高新技术企业，子公司兰州兰石超合金新材料有限公司首次通过高新技术企业认定，预计连续三 年可按15%税率缴纳企业所得税。 ...

根据《中华人民共和国企业所得税法》《中华人民共和国企业所得税法实施条例》等相关规定，公司、 检测公司、超合金公司本次通过高新技术企业认定后可以连续三年继续享受国家关于高新技术企业的相 关税收优惠政策，按15%的税率缴纳企业所得税。 格隆汇12月8日丨兰石重装(603169.SH)公布，近日，全国高新技术企业认定管理工作领导小组办公室公 布了《对甘肃省认定机构 2025 年认定报备的第一批高新技术企业进行备案的公告》，公司及子公司兰 州兰石检测技术有限公司（以下简称"检测公司"）重新认定为国家高新技术企业，子公司兰州兰石超合 金新材料有限公司（以下简称"超合金公司"）首次通过高新技术企业认定，证书编号分别为 GR202562000160、GR202562000174、GR202562000084。 ...

在问询阶段等待逾4个月后，安徽林平循环发展股份有限公司（以下简称"林平发展"）沪市主板IPO迎来 最新进展，公司近日对外披露了第二轮审核问询函回复。冲击上市背后，林平发展业绩波动较为明显， 公司2024年营收、净利双降；公司报告期内两项拳头产品单价也均持续下滑。另外，今年上半年，公司 账上长期、短期借款合计增长约3.42亿元。 拳头产品单价走低 北京商报记者注意到，今年上半年，林平发展账上长期、短期借款均出现了大幅增长。 "短期业绩下滑本身不构成IPO的致命障碍，但关键在于公司能否向市场证明其下滑的周期性与临时 性，而非趋势性恶化。监管层与投资者更关注的是公司的盈利质量、现金流韧性以及穿越周期的能 力。"资深企业管理专家、高级经济师董鹏对北京商报记者表示。 而对于2025年全年经营业绩预计情况，公司则在问询函回复中表示，2025年度预计实现营业收入约为 26.4亿—27.8亿元；预计实现归属净利润约为1.8亿—2亿元，均较2024年实现同比增长。（公司对2025 年度经营业绩预计为公司初步测算数据，未经注册会计师审计或审阅，且不构成公司的盈利预测或业绩 承诺。） 近期，林平发展主板IPO交出了第二轮审核问询答 ...

Core Viewpoint - Chao Yang Jin Da Titanium Industry Co., Ltd. (Jin Ti Co.) is preparing for its listing on the Beijing Stock Exchange, with a focus on high-end sponge titanium products used in aerospace and defense sectors. The company faces challenges including a significant reduction in fundraising, high levels of receivables, and low R&D investment compared to peers [1][9][18]. Group 1: Company Overview - Jin Ti Co. specializes in the research, production, and sales of sponge titanium products, with over ten years of experience in high-end applications [1]. - The actual controllers of the company are Zhao Chunlei and Wang Shuxia, who hold over 64% of the voting rights [3][4]. - The company has a history of financial issues, including a significant amount of outstanding loans exceeding 90 million yuan [5][6]. Group 2: Financial Performance - In the first three quarters, Jin Ti Co. reported revenue of 12.72 billion yuan and a net profit of 1.55 billion yuan, marking year-on-year increases of 12.43% and 52.68%, respectively [23]. - The average selling price of its main product, sponge titanium, has been declining, with prices per ton dropping from 72,600 yuan to 46,600 yuan over recent years [23][24]. - The company’s revenue from sponge titanium products accounted for over 90% of total sales, with aerospace-grade products being the primary contributor [23][24]. Group 3: Fundraising and Investment - Jin Ti Co. plans to raise 4.05 billion yuan through its IPO, a reduction of 3.45 billion yuan from the initial proposal [9][18]. - The company has faced scrutiny regarding its ability to absorb new production capacity, with a proposed expansion of 20,000 tons, which is 67% of its current capacity [11][14]. Group 4: Research and Development - The company’s R&D expenditure has been low, with a rate of around 1%, significantly lower than competitors like Baotai Co. and Longbai Group, which have rates exceeding 3% [18][21]. - Jin Ti Co. has received recognition as a high-tech enterprise, but questions remain about its ability to maintain this status given its low R&D investment and workforce composition [22][21]. Group 5: Operational Challenges - The company has high levels of accounts receivable and inventory, with accounts receivable increasing from 125 million yuan to 399 million yuan over recent years [25][26]. - Jin Ti Co. has experienced significant fluctuations in operating cash flow, with net outflows in 2022 and 2023, raising concerns about its financial stability [26].

证券代码：600426 证券简称：华鲁恒升 编号：临2025-074 山东华鲁恒升化工股份有限公司 根据全国高新技术企业认定管理工作领导小组办公室于2025年12月2日发布的《对湖北省认定机构2025 年认定报备的第一批高新技术企业进行备案的公告》，公司控股子公司华鲁恒升（荆州）有限公司（以 下简称"荆州子公司"）已通过了高新技术企业的认定，证书编号为GR202542000637。 根据《中华人民共和国企业所得税法》以及国家对高新技术企业的相关税收规定，荆州子公司通过高新 技术企业认定后，将连续三年享受国家关于高新技术企业的相关税收优惠政策，即按15%的税率缴纳企 业所得税。 特此公告。 山东华鲁恒升化工股份有限公司董事会 2025年12月4日 关于控股子公司通过高新技术企业认定的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 ...

（编辑 袁冠琳） 证券日报网讯 12月3日晚间，华鲁恒升发布公告称，公司控股子公司华鲁恒升（荆州）有限公司已通过 了高新技术企业的认定，根据相关税收规定，荆州子公司通过高新技术企业认定后，将连续三年享受国 家关于高新技术企业的相关税收优惠政策，即按15%的税率缴纳企业所得税。 ...